A 0 1 0 1 O
negative 2 10 2 10 B-pregnancy
serum 11 16 11 16 I-pregnancy
or 17 19 17 19 I-pregnancy
urine 20 25 20 25 I-pregnancy
pregnancy 26 35 26 35 I-pregnancy
test 36 40 36 40 O
is 41 43 41 43 O
required 44 52 44 52 O
at 53 55 53 55 O
screening 56 65 56 65 O
for 66 69 66 69 O
all 70 73 70 73 O
female 74 80 74 80 B-gender
patients 81 89 81 89 I-gender
of 90 92 90 92 O
childbearing 93 105 93 105 O
potential 106 115 106 115 O

ANC 0 3 116 119 B-clinical_variable
: 3 4 119 120 O
≥ 5 6 121 122 O
1500 7 11 123 127 B-lower_bound
/ 11 12 127 128 I-lower_bound
mcL 12 15 128 131 I-lower_bound

AST 0 3 132 135 B-clinical_variable
/ 3 4 135 136 O
ALT 4 7 136 139 B-clinical_variable
/ 7 8 139 140 O
alkaline 8 16 140 148 B-clinical_variable
phosphatase 17 28 149 160 I-clinical_variable
: 28 29 160 161 O
≤ 30 31 162 163 O
2.5 32 35 164 167 B-upper_bound
x 36 37 168 169 I-upper_bound
ULN 38 41 170 173 I-upper_bound

AST 0 3 174 177 B-clinical_variable
/ 3 4 177 178 I-clinical_variable
ALT 4 7 178 181 I-clinical_variable
/ 7 8 181 182 I-clinical_variable
alkaline 8 16 182 190 I-clinical_variable
phosphatase 17 28 191 202 I-clinical_variable
: 28 29 202 203 O
≤ 30 31 204 205 O
5x 32 34 206 208 B-upper_bound
ULN 35 38 209 212 I-upper_bound

Although 0 8 213 221 O
most 9 13 222 226 O
of 14 16 227 229 O
these 17 22 230 235 O
patients 23 31 236 244 O
will 32 36 245 249 O
have 37 41 250 254 O
regional 42 50 255 263 B-chronic_disease
nodal 51 56 264 269 I-chronic_disease
disease 57 64 270 277 I-chronic_disease
, 64 65 277 278 O
patients 66 74 279 287 O
with 75 79 288 292 O
no 80 82 293 295 O
nodal 83 88 296 301 O
disease 89 96 302 309 O
will 97 101 310 314 O
also 102 106 315 319 O
be 107 109 320 322 O
eligible 110 118 323 331 O

Arm 0 3 332 335 O
1 4 5 336 337 O
: 5 6 337 338 O
T2 7 9 339 341 B-lower_bound
- 9 10 341 342 O
T4 10 12 342 344 B-upper_bound
primary 13 20 345 352 B-cancer
tumors 21 27 353 359 I-cancer

Arm 0 3 360 363 O
3 4 5 364 365 O
: 5 6 365 366 O
Presence 7 15 367 375 O
of 16 18 376 378 O
disease 19 26 379 386 O
at 27 29 387 389 O
the 30 33 390 393 O
oropharynx 34 44 394 404 O
sub 45 48 405 408 O
- 48 49 408 409 O
sites 49 54 409 414 O
, 54 55 414 415 O
which 56 61 416 421 O
is 62 64 422 424 O
HPV 65 68 425 428 B-chronic_disease
- 68 69 428 429 O
related 69 76 429 436 O
as 77 79 437 439 O
verified 80 88 440 448 O
by 89 91 449 451 O
p16 92 95 452 455 O
, 95 96 455 456 O
a 97 98 457 458 O
surrogate 99 108 459 468 O
marker 109 115 469 475 O
of 116 118 476 478 O
HPV 119 122 479 482 O
, 122 123 482 483 O
or 124 126 484 486 O
HPV 127 130 487 490 B-chronic_disease
ISH 131 134 491 494 I-chronic_disease
or 135 137 495 497 O
PCR 138 141 498 501 B-treatment

Arm 0 3 502 505 O
3 4 5 506 507 O
: 5 6 507 508 O
T2T1 7 11 509 513 B-lower_bound
- 11 12 513 514 O
T4 12 14 514 516 B-upper_bound
primary 15 22 517 524 B-cancer
tumors 23 29 525 531 I-cancer

At 0 2 532 534 O
least 3 8 535 540 O
18 9 11 541 543 B-lower_bound
years 12 17 544 549 I-lower_bound
of 18 20 550 552 O
age 21 24 553 556 B-age

Calculated 0 10 557 567 O
GFR 11 14 568 571 B-clinical_variable
> 15 16 572 573 O
30 16 18 573 575 B-lower_bound
cc 19 21 576 578 I-lower_bound
/ 21 22 578 579 I-lower_bound
min 22 25 579 582 I-lower_bound

Diagnosis 0 9 583 592 O
of 10 12 593 595 O
selected 13 21 596 604 O
Stage 22 27 605 610 B-cancer
III 28 31 611 614 I-cancer
or 32 34 615 617 I-cancer
IVa 35 38 618 621 I-cancer
/ 38 39 621 622 I-cancer
b 39 40 622 623 I-cancer
HNSCC 41 46 624 629 I-cancer

Diagnosis 0 9 630 639 O
of 10 12 640 642 O
unknown 13 20 643 650 O
primary 21 28 651 658 B-cancer
squamous 29 37 659 667 I-cancer
cell 38 42 668 672 I-cancer
carcinoma 43 52 673 682 I-cancer
of 53 55 683 685 I-cancer
the 56 59 686 689 I-cancer
head 60 64 690 694 I-cancer
and 65 68 695 698 I-cancer
neck 69 73 699 703 I-cancer

Disease 0 7 704 711 O
at 8 10 712 714 O
the 11 14 715 718 O
nasopharyngeal 15 29 719 733 B-cancer
, 29 30 733 734 O
sinus 31 36 735 740 B-chronic_disease
, 36 37 740 741 O
oral 38 42 742 746 B-chronic_disease
cavity 43 49 747 753 I-chronic_disease
, 49 50 753 754 O
or 51 53 755 757 O
other 54 59 758 763 O
sub 60 63 764 767 O
- 63 64 767 768 O
site 64 68 768 772 O
not 69 72 773 776 O
specified 73 82 777 786 O
as 83 85 787 789 O
eligible 86 94 790 798 O

ECOG 0 4 799 803 B-clinical_variable
performance 5 16 804 815 I-clinical_variable
status 17 23 816 822 I-clinical_variable
< 24 25 823 824 O
3 26 27 825 826 B-upper_bound

ECOG 0 4 827 831 B-clinical_variable
performance 5 16 832 843 I-clinical_variable
status 17 23 844 850 I-clinical_variable
≤ 24 25 851 852 O
1 26 27 853 854 B-upper_bound

Hemoglobin 0 10 855 865 B-clinical_variable
> 11 12 866 867 O
9.0 13 16 868 871 B-lower_bound
g 17 18 872 873 I-lower_bound
/ 18 19 873 874 I-lower_bound
dL 19 21 874 876 I-lower_bound

History 0 7 877 884 O
of 8 10 885 887 O
allergic 11 19 888 896 O
reactions 20 29 897 906 O
attributed 30 40 907 917 O
to 41 43 918 920 O
compounds 44 53 921 930 B-allergy_name
of 54 56 931 933 I-allergy_name
similar 57 64 934 941 I-allergy_name
chemical 65 73 942 950 I-allergy_name
or 74 76 951 953 I-allergy_name
biologic 77 85 954 962 I-allergy_name
composition 86 97 963 974 I-allergy_name
to 98 100 975 977 I-allergy_name
any 101 104 978 981 I-allergy_name
of 105 107 982 984 I-allergy_name
the 108 111 985 988 I-allergy_name
agents 112 118 989 995 I-allergy_name
used 119 123 996 1000 O
in 124 126 1001 1003 O
this 127 131 1004 1008 O
study 132 137 1009 1014 O

History 0 7 1015 1022 O
of 8 10 1023 1025 O
prior 11 16 1026 1031 O
invasive 17 25 1032 1040 B-cancer
malignancy 26 36 1041 1051 I-cancer
diagnosed 37 46 1052 1061 O
within 47 53 1062 1068 O
3 54 55 1069 1070 B-upper_bound
years 56 61 1071 1076 I-upper_bound
prior 62 67 1077 1082 I-upper_bound
to 68 70 1083 1085 O
study 71 76 1086 1091 O
enrollment 77 87 1092 1102 O

If 0 2 1103 1105 O
currently 3 12 1106 1115 O
taking 13 19 1116 1122 O
either 20 26 1123 1129 O
of 27 29 1130 1132 O
these 30 35 1133 1138 O
medications 36 47 1139 1150 O
, 47 48 1150 1151 O
patient 49 56 1152 1159 O
must 57 61 1160 1164 O
discontinue 62 73 1165 1176 O
for 74 77 1177 1180 O
one 78 81 1181 1184 O
week 82 86 1185 1189 O
before 87 93 1190 1196 O
receiving 94 103 1197 1206 O
treatment 104 113 1207 1216 O
with 114 118 1217 1221 O
nab 119 122 1222 1225 B-treatment
- 122 123 1225 1226 I-treatment
paclitaxel 123 133 1226 1236 I-treatment

Known 0 5 1237 1242 O
to 6 8 1243 1245 O
be 9 11 1246 1248 O
HIV 12 15 1249 1252 B-chronic_disease
- 15 16 1252 1253 O
positive 16 24 1253 1261 O
on 25 27 1262 1264 O
combination 28 39 1265 1276 O
antiretroviral 40 54 1277 1291 B-treatment
therapy 55 62 1292 1299 I-treatment
because 63 70 1300 1307 O
of 71 73 1308 1310 O
the 74 77 1311 1314 O
potential 78 87 1315 1324 O
for 88 91 1325 1328 O
pharmacokinetic 92 107 1329 1344 O
interactions 108 120 1345 1357 O
with 121 125 1358 1362 O
the 126 129 1363 1366 O
study 130 135 1367 1372 O
agents 136 142 1373 1379 O

Patients 0 8 1380 1388 O
with 9 13 1389 1393 O
T1 14 16 1394 1396 B-cancer
tumors 17 23 1397 1403 I-cancer

Peripheral 0 10 1404 1414 B-clinical_variable
neuropathy 11 21 1415 1425 I-clinical_variable
> 22 23 1426 1427 O
grade 24 29 1428 1433 B-lower_bound
1 30 31 1434 1435 I-lower_bound

Platelets 0 9 1436 1445 B-clinical_variable
: 9 10 1445 1446 O
> 11 12 1447 1448 O
100,000 13 20 1449 1456 B-lower_bound
/ 20 21 1456 1457 I-lower_bound
mcL 21 24 1457 1460 I-lower_bound

Platelets 0 9 1461 1470 B-clinical_variable
: 9 10 1470 1471 O
≥ 11 12 1472 1473 O
100,000 13 20 1474 1481 B-lower_bound
/ 20 21 1481 1482 I-lower_bound
mcL 21 24 1482 1485 I-lower_bound

Pregnant 0 8 1486 1494 B-pregnancy
and/or 9 15 1495 1501 O
breastfeeding 16 29 1502 1515 O

Prior 0 5 1516 1521 B-treatment
chemotherapy 6 18 1522 1534 I-treatment
, 18 19 1534 1535 O
prior 20 25 1536 1541 B-treatment
EGFR 26 30 1542 1546 I-treatment
targeted 31 39 1547 1555 I-treatment
therapy 40 47 1556 1563 I-treatment
, 47 48 1563 1564 O
or 49 51 1565 1567 O
prior 52 57 1568 1573 B-treatment
radiation 58 67 1574 1583 I-treatment
therapy 68 75 1584 1591 I-treatment
for 76 79 1592 1595 O
HNSCC 80 85 1596 1601 B-cancer

Pulmonary 0 9 1602 1611 O
: 9 10 1611 1612 O
no 11 13 1613 1615 O
requirement 14 25 1616 1627 O
for 26 29 1628 1631 O
supplemental 30 42 1632 1644 B-treatment
oxygen 43 49 1645 1651 I-treatment
and 50 53 1652 1655 O
no 54 56 1656 1658 O
evidence 57 65 1659 1667 O
of 66 68 1668 1670 O
moderate 69 77 1671 1679 O
- 77 78 1679 1680 O
severe 78 84 1680 1686 O
chronic 85 92 1687 1694 B-chronic_disease
obstructive 93 104 1695 1706 I-chronic_disease
pulmonary 105 114 1707 1716 I-chronic_disease
disease 115 122 1717 1724 I-chronic_disease
( 123 124 1725 1726 I-chronic_disease
COPD 124 128 1726 1730 I-chronic_disease
) 128 129 1730 1731 I-chronic_disease
by 130 132 1732 1734 O
pulmonary 133 142 1735 1744 O
function 143 151 1745 1753 O
tests 152 157 1754 1759 O
( 158 159 1760 1761 O
PFTs 159 163 1761 1765 O
) 163 164 1765 1766 O

Pulmonary 0 9 1767 1776 O
: 9 10 1776 1777 O
patients 11 19 1778 1786 O
with 20 24 1787 1791 O
a 25 26 1792 1793 O
requirement 27 38 1794 1805 O
for 39 42 1806 1809 O
supplemental 43 55 1810 1822 O
oxygen 56 62 1823 1829 O
or 63 65 1830 1832 O
evidence 66 74 1833 1841 O
of 75 77 1842 1844 O
moderate 78 86 1845 1853 O
- 86 87 1853 1854 O
severe 87 93 1854 1860 O
COPD 94 98 1861 1865 B-chronic_disease
by 99 101 1866 1868 O
PFTs 102 106 1869 1873 O
are 107 110 1874 1877 O
permitted 111 120 1878 1887 O
to 121 123 1888 1890 O
enroll 124 130 1891 1897 O

Receiving 0 9 1898 1907 O
any 10 13 1908 1911 O
other 14 19 1912 1917 O
investigational 20 35 1918 1933 B-treatment
agents 36 42 1934 1940 I-treatment

Serum 0 5 1941 1946 B-clinical_variable
creatinine 6 16 1947 1957 I-clinical_variable
: 16 17 1957 1958 O
< 18 19 1959 1960 O
1.5 20 23 1961 1964 B-upper_bound
mg 24 26 1965 1967 I-upper_bound
/ 26 27 1967 1968 I-upper_bound
dL 27 29 1968 1970 I-upper_bound
or 30 32 1971 1973 O
calculated 33 43 1974 1984 B-clinical_variable
GFR 44 47 1985 1988 I-clinical_variable
≥ 48 49 1989 1990 O
75 50 52 1991 1993 B-lower_bound
cc 53 55 1994 1996 I-lower_bound
/ 55 56 1996 1997 I-lower_bound
min 56 59 1997 2000 I-lower_bound

Should 0 6 2001 2007 O
a 7 8 2008 2009 O
woman 9 14 2010 2015 B-gender
become 15 21 2016 2022 B-pregnancy
pregnant 22 30 2023 2031 I-pregnancy
or 31 33 2032 2034 O
suspect 34 41 2035 2042 O
she 42 45 2043 2046 O
is 46 48 2047 2049 B-pregnancy
pregnant 49 57 2050 2058 I-pregnancy
while 58 63 2059 2064 O
participating 64 77 2065 2078 O
in 78 80 2079 2081 O
this 81 85 2082 2086 O
study 86 91 2087 2092 O
, 91 92 2092 2093 O
she 93 96 2094 2097 O
must 97 101 2098 2102 O
inform 102 108 2103 2109 O
her 109 112 2110 2113 O
treating 113 121 2114 2122 O
physician 122 131 2123 2132 O
immediately 132 143 2133 2144 O

T2 0 2 2145 2147 B-lower_bound
- 2 3 2147 2148 O
T4 3 5 2148 2150 B-upper_bound
primary 6 13 2151 2158 B-cancer
tumors 14 20 2159 2165 I-cancer

Taking 0 6 2166 2172 O
cimetidine 7 17 2173 2183 B-treatment
or 18 20 2184 2186 O
allopurinol 21 32 2187 2198 B-treatment

Total 0 5 2199 2204 B-clinical_variable
bilirubin 6 15 2205 2214 I-clinical_variable
≤ 16 17 2215 2216 O
1.5 18 21 2217 2220 B-upper_bound
mg 22 24 2221 2223 I-upper_bound
/ 24 25 2223 2224 I-upper_bound
dL 25 27 2224 2226 I-upper_bound

Total 0 5 2227 2232 O
bilirubin 6 15 2233 2242 B-clinical_variable
≤ 16 17 2243 2244 O
2.0 18 21 2245 2248 B-upper_bound
mg 22 24 2249 2251 I-upper_bound
/ 24 25 2251 2252 I-upper_bound
dL 25 27 2252 2254 I-upper_bound

Uncontrolled 0 12 2255 2267 O
intercurrent 13 25 2268 2280 O
illness 26 33 2281 2288 O
including 34 43 2289 2298 O
, 43 44 2298 2299 O
but 45 48 2300 2303 O
not 49 52 2304 2307 O
limited 53 60 2308 2315 O
to 61 63 2316 2318 O
, 63 64 2318 2319 O
ongoing 65 72 2320 2327 B-chronic_disease
or 73 75 2328 2330 I-chronic_disease
active 76 82 2331 2337 I-chronic_disease
serious 83 90 2338 2345 I-chronic_disease
infection 91 100 2346 2355 I-chronic_disease
, 100 101 2355 2356 O
symptomatic 102 113 2357 2368 B-chronic_disease
congestive 114 124 2369 2379 I-chronic_disease
heart 125 130 2380 2385 I-chronic_disease
failure 131 138 2386 2393 I-chronic_disease
, 138 139 2393 2394 O
unstable 140 148 2395 2403 B-chronic_disease
angina 149 155 2404 2410 I-chronic_disease
pectoris 156 164 2411 2419 I-chronic_disease
, 164 165 2419 2420 O
cardiac 166 173 2421 2428 B-chronic_disease
arrhythmia 174 184 2429 2439 I-chronic_disease
, 184 185 2439 2440 O
or 186 188 2441 2443 O
serious 189 196 2444 2451 B-chronic_disease
psychiatric 197 208 2452 2463 I-chronic_disease
illness 209 216 2464 2471 I-chronic_disease
/ 216 217 2471 2472 I-chronic_disease
social 217 223 2472 2478 I-chronic_disease
situations 224 234 2479 2489 I-chronic_disease
that 235 239 2490 2494 O
would 240 245 2495 2500 O
limit 246 251 2501 2506 O
compliance 252 262 2507 2517 O
with 263 267 2518 2522 O
study 268 273 2523 2528 O
requirements 274 286 2529 2541 O

Women 0 5 2542 2547 B-gender
of 6 8 2548 2550 O
childbearing 9 21 2551 2563 O
potential 22 31 2564 2573 O
and 32 35 2574 2577 O
men 36 39 2578 2581 O
must 40 44 2582 2586 O
agree 45 50 2587 2592 B-contraception_consent
to 51 53 2593 2595 I-contraception_consent
use 54 57 2596 2599 I-contraception_consent
adequate 58 66 2600 2608 I-contraception_consent
contraception 67 80 2609 2622 I-contraception_consent
( 81 82 2623 2624 O
hormonal 82 90 2624 2632 B-contraception_consent
or 91 93 2633 2635 O
barrier 94 101 2636 2643 B-contraception_consent
method 102 108 2644 2650 I-contraception_consent
of 109 111 2651 2653 I-contraception_consent
birth 112 117 2654 2659 I-contraception_consent
control 118 125 2660 2667 I-contraception_consent
, 125 126 2667 2668 O
abstinence 127 137 2669 2679 B-contraception_consent
) 137 138 2679 2680 O
prior 139 144 2681 2686 O
to 145 147 2687 2689 O
study 148 153 2690 2695 O
entry 154 159 2696 2701 O
, 159 160 2701 2702 O
for 161 164 2703 2706 O
the 165 168 2707 2710 O
duration 169 177 2711 2719 O
of 178 180 2720 2722 O
study 181 186 2723 2728 O
participation 187 200 2729 2742 O
, 200 201 2742 2743 O
and 202 205 2744 2747 O
for 206 209 2748 2751 O
3 210 211 2752 2753 B-upper_bound
months 212 218 2754 2760 I-upper_bound
after 219 224 2761 2766 I-upper_bound
completing 225 235 2767 2777 O
treatment 236 245 2778 2787 B-treatment

malignancies 0 12 2788 2800 B-cancer
with 13 17 2801 2805 O
a 18 19 2806 2807 O
negligible 20 30 2808 2818 O
risk 31 35 2819 2823 O
of 36 38 2824 2826 O
metastasis 39 49 2827 2837 B-cancer
or 50 52 2838 2840 O
death 53 58 2841 2846 O
( 59 60 2847 2848 O
e.g. 60 64 2848 2852 O
, 64 65 2852 2853 O
expected 66 74 2854 2862 B-clinical_variable
5 75 76 2863 2864 I-clinical_variable
- 76 77 2864 2865 I-clinical_variable
year 77 81 2865 2869 I-clinical_variable
OS 82 84 2870 2872 I-clinical_variable
> 85 86 2873 2874 O
90 87 89 2875 2877 B-lower_bound
% 89 90 2877 2878 I-lower_bound
) 90 91 2878 2879 O
that 92 96 2880 2884 O
were 97 101 2885 2889 O
treated 102 109 2890 2897 O
with 110 114 2898 2902 O
an 115 117 2903 2905 O
expected 118 126 2906 2914 O
curative 127 135 2915 2923 O
outcome 136 143 2924 2931 O
, 143 144 2931 2932 O
such 145 149 2933 2937 O
as 150 152 2938 2940 O
squamous 153 161 2941 2949 B-cancer
cell 162 166 2950 2954 I-cancer
carcinoma 167 176 2955 2964 I-cancer
of 177 179 2965 2967 I-cancer
the 180 183 2968 2971 I-cancer
skin 184 188 2972 2976 I-cancer
, 188 189 2976 2977 O
in 190 192 2978 2980 B-cancer
- 192 193 2980 2981 I-cancer
situ 193 197 2981 2985 I-cancer
carcinoma 198 207 2986 2995 I-cancer
of 208 210 2996 2998 I-cancer
the 211 214 2999 3002 I-cancer
cervix 215 221 3003 3009 I-cancer
uteri 222 227 3010 3015 I-cancer
, 227 228 3015 3016 O
non 229 232 3017 3020 B-cancer
- 232 233 3020 3021 I-cancer
melanomatous 233 245 3021 3033 I-cancer
skin 246 250 3034 3038 I-cancer
cancer 251 257 3039 3045 I-cancer
, 257 258 3045 3046 O
carcinoma 259 268 3047 3056 B-cancer
in 269 271 3057 3059 I-cancer
situ 272 276 3060 3064 I-cancer
of 277 279 3065 3067 I-cancer
the 280 283 3068 3071 I-cancer
breast 284 290 3072 3078 I-cancer
, 290 291 3078 3079 O
or 292 294 3080 3082 O
incidental 295 305 3083 3093 O
histological 306 318 3094 3106 O
finding 319 326 3107 3114 O
of 327 329 3115 3117 O
prostate 330 338 3118 3126 B-cancer
cancer 339 345 3127 3133 I-cancer
( 346 347 3134 3135 O
TNM 347 350 3135 3138 B-clinical_variable
stage 351 356 3139 3144 I-clinical_variable
of 357 359 3145 3147 O
T1a 360 363 3148 3151 O
or 364 366 3152 3154 O
T1b 367 370 3155 3158 O

these 0 5 3159 3164 O
patients 6 14 3165 3173 O
are 15 18 3174 3177 O
at 19 21 3178 3180 O
increased 22 31 3181 3190 O
risk 32 36 3191 3195 O
of 37 39 3196 3198 O
lethal 40 46 3199 3205 B-chronic_disease
infections 47 57 3206 3216 I-chronic_disease
when 58 62 3217 3221 O
treated 63 70 3222 3229 O
with 71 75 3230 3234 O
marrow 76 82 3235 3241 B-treatment
suppressive 83 94 3242 3253 I-treatment
therapy 95 102 3254 3261 I-treatment

